TNXP Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.

$0.42
As of 12/03/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/03/2012
Outstanding shares:  439,590,272
Average volume:  22,030,346
Market cap:   $192,452,621
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    890260706
ISIN:        US8902607063
Sedol:      BK26FH7
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.83
PS ratio:   0.00
Return on equity:   -39.44%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy